Geburtshilfe und Frauenheilkunde, Table of Contents Geburtshilfe Frauenheilkd 2013; 73(4): R27-R46DOI: 10.1055/s-0032-1328498 GebFra-Weiterbildung | Refresher Georg Thieme Verlag KG Stuttgart · New York Aufgaben der Pathologie in der Begutachtung von Präparaten aus der Frauenheilkunde J. D. Strehl , D. L. Wachter , A. Hartmann Recommend Article Abstract Buy Article Full Text References Literatur 1 Laucirica R. Intraoperative assessment of the breast: guidelines and potential pitfalls. Arch Pathol Lab Med 2005; 129: 1565-1574 2 Leitlinienprogramm Onkologie, DKG, Deutsche Krebshilfe, AWMF. Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. 2012. Im Internet: www.awmf.org 3 Cserni G, Amendoeira I, Apostolikas N et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 2003; 39: 1654-1667 4 Kuehn T, Bembenek A, Decker T et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 2005; 103: 451-461 5 Strehl JD, Wachter DL, Fasching PA et al. Invasive breast cancer: recognition of molecular subtypes. Breast Care (Basel) 2011; 6: 258-264 6 Perou CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752 7 Sorlie T, Perou CM, Tibshirani R et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-10874 8 Rouzier R, Perou CM, Symmans WF et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11: 5678-5685 9 Fasching PA, Heusinger K, Haeberle L et al. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer 2011; 11: 486 10 Cheang MC, Chia SK, Voduc D et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst 2009; 101: 736-750 11 Balbi G, Napolitano A, Giordano F et al. Role of the association of high-risk HPV identified by real-time PCR in cervical preneoplastic lesions. Eur J Gynaecol Oncol 2012; 33: 467-471 12 Tsoumpou I, Arbyn M, Kyrgiou M et al. p 16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 2009; 35: 210-220 13 Negri G, Bellisano G, Carico E et al. Usefulness of p 16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri. Int J Gynecol Pathol 2011; 30: 407-413 14 Strehl JD, Mehlhorn G, Koch MC et al. HIV-associated hypertrophic herpes simplex genitalis with concomitant early invasive squamous cell carcinoma mimicking advanced genital cancer: case report and literature review. Int J Gynecol Pathol 2012; 31: 286-293 15 Yemelyanova A, Vang R, Kshirsagar M et al. Immunohistochemical staining patterns of p 53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis. Mod Pathol 2011; 24: 1248-1253 16 Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol 2001; 20: 31-47 17 Wachter DL, Thiel F, Agaimy A. Subinvolution of the placental site 6 years after last delivery. Int J Gynecol Pathol 2011; 30: 581-582 18 Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 2004; 164: 1511-1518 19 Vang R, Shih Ie M, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology 2013; 62: 44-58 20 Wachter DL, Thiel F, Agaimy A. Foreign body reaction after laparoscopic oxiplex administration mimicking peritoneal adenomucinosis: a potential pitfall in frozen section. Int J Gynecol Pathol 2012; 31: 542-544 21 Munksgaard PS, Blaakaer J. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Gynecologic Oncology 2012; 124: 164-169